Aflac Cancer Center and Blood Disorders Service, Emory University, Atlanta, GA 30322, USA.
Haemophilia. 2010 Sep 1;16(5):711-6. doi: 10.1111/j.1365-2516.2009.02145.x. Epub 2009 Dec 16.
Many patients with mild inherited bleeding disorders such as von Willebrand disease (VWD), mild haemophilia A (HA) and platelet function defects (PFD) undergo adenoidectomy and/or tonsillectomy (AT) procedures each year. Management of bleeding in these patients can be challenging, as little published data exist to guide haemostatic management during these relatively common procedures. Therefore, the literature was reviewed to identify AT procedures in patients with 1-deamino-8-D-argine vasopressin responsive mild bleeding disorders. The review revealed no randomized prospective trials of haemostatic management in this patient population. Case reports and small case series identified 144 patients who had AT procedures. Frequency of desmopressin and antifibrinolytic dosing varied widely. Fifteen percentage of patients experienced postoperative bleeding with nearly half being early (<24 h) bleeding and half being late (>24 h) bleeding. Hyponatraemia complicated the procedures in 47% of cases and six hyponatremic seizures were reported. Issues identified by this review that need to be addressed in future clinical trials include type and amount of fluid restriction when utilizing desmopressin, duration of antifibrinolytic therapy and duration and frequency of desmopressin dosing.
许多患有轻度遗传性出血性疾病(如血管性血友病 [VWD]、轻度血友病 A [HA]和血小板功能缺陷 [PFD])的患者每年都要接受腺样体切除术和/或扁桃体切除术(AT)。由于缺乏指导这些相对常见手术中止血管理的大量已发表数据,因此管理这些患者的出血可能具有挑战性。因此,回顾了文献,以确定对 1-脱氨-8-D-精氨酸加压素反应性轻度出血性疾病患者的 AT 手术。该综述未发现针对该患者人群止血管理的随机前瞻性试验。病例报告和小病例系列确定了 144 名接受 AT 手术的患者。去氨加压素和抗纤维蛋白溶解剂的给药频率差异很大。15%的患者发生术后出血,近一半为早期(<24 小时)出血,一半为晚期(>24 小时)出血。47%的病例出现低钠血症,报告了 6 例低钠血症发作。本综述中确定的需要在未来临床试验中解决的问题包括在使用去氨加压素时限制液体的类型和数量、抗纤维蛋白溶解治疗的持续时间以及去氨加压素的给药持续时间和频率。